Wednesday, 4 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Results Update

Zydus Lifesciences Results Update

Zydus Lifesciences reported FY26 revenues of ₹27,148 Crore and approved a ₹1,100 Crore share buyback. Strong performance across segments supports the multi-year growth outlook.

Key figures
Value₹1,100 Cr
Source

BSE filing, NSE: ZYDUSLIFE. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Zydus Lifesciences Ltd: key numbers

Share price
₹1,199.70
Market cap
₹1,20,718 Cr
Revenue (annual)
₹27,148 Cr
Net profit (annual)
₹5,040 Cr
P/E (TTM)
26.8×Sector 41.3×
Promoter holding
75.01%+0.00% QoQ
FII holding
7.05%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Zydus Lifesciences Ltd

All →

Other results update announcements

All →